Updating the MASH pharmacotherapy landscape: a network meta-analysis incorporating SGLT2 inhibitors and emerging combination therapies. [PDF]
Tang M, Ma Y, Wang Y.
europepmc +1 more source
Exploratory analyses of clinical trials - what can they tell us and what are the potential pitfalls? [PDF]
europepmc +1 more source
Integrating a pilot study and large trial into one adaptive design. [PDF]
Dai J +4 more
europepmc +1 more source
Science policies and practice of including and excluding women from clinical studies: focus on cardiovascular research. [PDF]
Kovalsky A, Levitan I.
europepmc +1 more source
The promise of immunotherapy in the treatment of sarcoma: A state-of-the-art review of practice changing research and future directions. [PDF]
Kulkarni NJ, Kelly CM, Bartlett EK.
europepmc +1 more source
Therapeutic strategies in intracerebral hemorrhage: from hematoma stabilization to alleviating secondary brain injury. [PDF]
Hsieh PF, Liu YB, Cordonnier C, Tsai HH.
europepmc +1 more source
Current status of vaccine clinical trials registered on China's Drug Trial Registration and information disclosure platform, 2013-2024. [PDF]
Zhong S, Lin Z, Li J, Xie F, Zhang D.
europepmc +1 more source
Related searches:
Plantar warts are cutaneous lesions on the plantar aspect of the foot caused by the infection of keratinocytes with the human papillomavirus (HPV). The severity and magnitude of warts can vary, but they cause pain and discomfort for all age groups. The treatment for plantar warts remains a continuing challenge.
Mahkameh, Yousefpour +5 more
openaire +2 more sources
Previous in vitro and in vivo studies indicated that catechins from the tea plant (Camellia sinensis) have a therapeutic effect on herpes simplex virus infections. The aim of this study was to clinically evaluate a topical proprietary formulation containing lipophilic catechins (AverTeaX, Camellix, LLC, Evans, GA, USA) on recurrent herpes labialis.A ...
Man, Zhao +8 more
openaire +2 more sources
To determine the effect of enclomiphene citrate in men with secondary hypogonadism.Phase II clinical trial.Community dwelling men making visits to physician offices.Men with secondary hypogonadism.Oral administration of enclomiphene citrate or 1% topical T gel.Luteinizing hormone, FSH, T, and semen analysis.Treatment with enclomiphene citrate resulted ...
Ronald D, Wiehle +5 more
openaire +2 more sources

